Risks and benefits from CDK inhibitors for advanced HR+ Her 2- breast cancer.

AbemaciclibRibociclibPalbociclibhormonal therapybreast cancermeta-analysis

from Cancer via ola Kala on Inoreader http://ift.tt/2x7togx
via IFTTT